SolasCure demonstrates proof-of-concept in Phase lla safety trial of Aurase Wound Gel Post author: Post published:December 12, 2023 Post category:uncategorized SolasCure today announced the results of its proof-of-concept, first-in-human, Phase IIa safety study. You Might Also Like Understanding the mechanisms behind cystic fibrosis infections April 4, 2024 New AI method accurately predicts male infertility from hormone levels, bypassing need for semen analysis August 4, 2024 If you’re poor, fertility treatment can be out of reach February 26, 2024
New AI method accurately predicts male infertility from hormone levels, bypassing need for semen analysis August 4, 2024